# Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

> **NCT01984086** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 60 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Salbutamol Sulphate 150mcg UD-DPI Blister(1.6% blend)
- **DRUG:** Salbutamol Sulphate 200mcg UD-DPI Blister(1.6% blend)
- **DRUG:** Salbutamol Sulphate 250mcg UD-DPI Blister(1.6% blend)
- **DRUG:** Salbutamol Sulphate 200mcg UD-DPI Blister(1% blend)
- **DRUG:** Salbutamol Diskus 200mcg Blister
- **DRUG:** Salbutamol MDI 100mcg
- **DRUG:** Salbutamol Sulphate UD-DPI Blister (selected from Part A)
- **DRUG:** Salbutamol Sulphate 250mcg UD-DPI Blister (selected from Part A)
- **DRUG:** Salbutamol Diskus 200mcg Blister without activated charcoal
- **DRUG:** Salbutamol Diskus 200mcg Blister with activated charcoal
- **DRUG:** Salbutamol MDI 100mcg without activated charcoal
- **DRUG:** Salbutamol MDI 100mcg with activated charcoal

## Key facts

- **NCT ID:** NCT01984086
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-21
- **Primary completion:** 2014-05-26
- **Final completion:** 2014-05-26
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01984086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01984086, "Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01984086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*